Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 4, 1996, Pages 616-622

  Yagi, Naomi ^a   Kiuchi, Takashi ^a   Satoh, Hayato ^a   Terashima, Yuhji ^a   Kenmotsu, Harumi ^a   Sekikawa, Hitoshi ^a   Takada, Masahiko ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

bioavailability; diuretic effect; furosemide; furosemide glucuronide; retarded capsule; tablet

Indexed keywords

FUROSEMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; DIURESIS; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG ADMINISTRATION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; URINARY EXCRETION;

EID: 0029913893     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.616     Document Type: Article

References (20)

1. A part of this study was presented at the 11th Annual Meeting of Japan TDM, Sapporo, June 1994.
2. Smith D. E., Hyneck M. L., Berardi R. R., Port F. K., J. Pharm. Sci., 74, 603-607 (1985).
3. Keller E., Seyler H. G., Schollmeyer P., Clin. Pharmacol. Ther., 32, 442-449 (1982).
4. Uchino K., Isozaki S., Amano J., Tanaka N., Saitoh Y., Nakagawa F., Tamura Z., Oka H., J. Pharmacobio-Dyn., 6, 684-691 (1983).
5. Ebihara A., Tawara K., Oka T., Arzneim.-Forsch., 33, 163-166 (1983).
6. Beermann B., Clin. Pharmacol. Ther., 32, 584-591 (1982).
7. Smith D. E., Lin E. T., Benet L. Z., Drug Metab. Dispos., 8. 337-342 (1980).
8. Aranda J. V., Lambert C., Perez J., Turmen T., Sitar D.S., J. Pediat., 101, 777-781 (1982).
9. Hammarlund M., Benet L. Z., J. Pharmacokin. Biopharm., 17, 1-46 (1989).
10. Sekikawa H., Vagi N., Oda K., Kenmotsu H., Takada M., Chen H., Lin E. T., Benet L. Z., Biol. Pharm. Bull., 18, 447-453 (1995).
11. Yagi N., Kenmotsu H., Sekikawa H., Takada M., Chem. Pharm. Bull., 39, 454-457 (1991).
12. Sekikawa H., Yagi N., Lin E. T., Benet L. Z., Biol. Pharm. Bull., 18, 134-139 (1995).
13. Hammarlund M. M., Odlind B., Paalzow L. K., J. Pharm. Exp. Ther., 233, 447-453 (1985).
14. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., Int. J. Pharm., 10, 291-300 (1982).
15. Smith P. C., Hasegawa J., Langendijk P. N. J., Drug Metab. Dispos., 13, 110-112 (1985).
16. Kovar K. A., Wojtovicz G. P., Auterhoff H., Arch. Pharm., 307, 657-662 (1974).
17. Doluisio J. T., LaPiana J. C., Wilkinson G. R., Dittert L. W., Antimicrob. Agents Chemother., 1969, 49-55 (1970).
18. Burg M. B., Kidney Int., 9, 189-197 (1976).
19. Zhu J., Koizumi T., J. Pharmacobio-Dyn., 10, 377-383 (1987).
20. Orita Y., Ando A., Urakabe S., Arzneim.-Forsch., 26, 11-13. (1976).